Transaction · 0001982614-26-000004

Jeggle Helmut Wolfgang

Jeggle Helmut Wolfgang, DIR, reported an open-market or private purchase at Bambusa Therapeutics, Inc. involving 375000.000000 shares for an estimated $6000000.00. Reported holdings after the transaction were 9264301.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PDIR
BBTXBambusa Therapeutics, Inc.
Trade date
Nov 02, 2026
Filing date
Nov 02, 2026
View on SEC Insider profile
Disclosed value$6.00MShares × reported price
Shares traded375k$16.00 per share
Holdings after9.26MIndirect · See footnote
% of reported position traded4.22%This security and ownership context
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 8,889,301 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

BBTX price since this filing

Daily closing prices, with the filing date and available return windows
BBTX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001982614-26-000004
Common Stock
Transaction date
Nov 02, 2026
Filed Nov 02, 2026, 09:06 PM · 0d delay
Shares
375,000 sh
$16.00 per share
Estimated value
$6.00M
Computed from shares × price
Holdings after
9,264,301 sh
Indirect · See footnote

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Director Buy Large Buy 10% Owner Buy
Filing-only score

+32 points

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • director_buy+6 points

    is_director = true

    Director open-market purchase.
  • large_buy_absolute+10 points

    large-buy signal with absolute_triggered = true

    Open-market purchase exceeds the configured absolute threshold.
  • timely_filing+4 points

    reporting_delay_days = 0

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    All shares of the preferred stock, par value $0.00001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.00001 per share ("Com…

  2. F2

    Shares held by Salvia Investment GmbH ("Salvia"). The Reporting Person is the Managing Director of Salvia GmbH and has sole voting and dispositive power with respect to the shares held by Salvia. The…

Original filing · 0001982614-26-000004
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

BBTX